Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Freeman

Showing results (201-210 of 244) with videos related to

Pageof 25
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2007
Plexin-B1 mutations in prostate cancerOscar Gee-Wan Wong, Tharani Nitkunan, Izumi Oinuma, et al.
BMJ Open|April 5, 2023
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocolAqua Asif, Arjun Nathan, Alexander Ng, et al.
BJU International|September 28, 2020
NeuroSAFE frozen section during robot-assisted radical prostatectomy: peri-operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trialEoin Dinneen, Aiman Haider, Jack Grierson, et al.
The Journal of Urology|July 24, 2019
Comparison of Transrectal Ultrasound Biopsy to Transperineal Template Mapping Biopsies Stratified by Multiparametric Magnetic Resonance Imaging Score in the PROMIS TrialCatherine E Lovegrove, Saiful Miah, Ahmed El-Shater Bosaily, et al.
BMJ Open|April 9, 2022
Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancerSaurabh Singh, Manju Mathew, Thomy Mertzanidou, et al.
Scientific Reports|September 3, 2020
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancerSabina Luszczak, Benjamin S Simpson, Urszula Stopka-Farooqui, et al.
Scientific Reports|November 12, 2020
Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancerSabina Luszczak, Benjamin S Simpson, Urszula Stopka-Farooqui, et al.
Cancer Research|June 22, 2016
CSN1 Somatic Mutations in Penile Squamous Cell CarcinomaAndrew Feber, Daniel C Worth, Ankur Chakravarthy, et al.
Radiology|August 2, 2022
Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE StudySaurabh Singh, Harriet Rogers, Baris Kanber, et al.
European Urology Focus|April 8, 2023
Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate LesionsVasilis Stavrinides, Ece Eksi, Ron Finn, et al.
Pageof 25

Showing results (201-210 of 244) with videos related to

Sort By:
Pageof 25
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2007
Plexin-B1 mutations in prostate cancerOscar Gee-Wan Wong, Tharani Nitkunan, Izumi Oinuma, et al.
BMJ Open|April 5, 2023
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocolAqua Asif, Arjun Nathan, Alexander Ng, et al.
BJU International|September 28, 2020
NeuroSAFE frozen section during robot-assisted radical prostatectomy: peri-operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trialEoin Dinneen, Aiman Haider, Jack Grierson, et al.
The Journal of Urology|July 24, 2019
Comparison of Transrectal Ultrasound Biopsy to Transperineal Template Mapping Biopsies Stratified by Multiparametric Magnetic Resonance Imaging Score in the PROMIS TrialCatherine E Lovegrove, Saiful Miah, Ahmed El-Shater Bosaily, et al.
BMJ Open|April 9, 2022
Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancerSaurabh Singh, Manju Mathew, Thomy Mertzanidou, et al.
Scientific Reports|September 3, 2020
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancerSabina Luszczak, Benjamin S Simpson, Urszula Stopka-Farooqui, et al.
Scientific Reports|November 12, 2020
Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancerSabina Luszczak, Benjamin S Simpson, Urszula Stopka-Farooqui, et al.
Cancer Research|June 22, 2016
CSN1 Somatic Mutations in Penile Squamous Cell CarcinomaAndrew Feber, Daniel C Worth, Ankur Chakravarthy, et al.
Radiology|August 2, 2022
Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE StudySaurabh Singh, Harriet Rogers, Baris Kanber, et al.
European Urology Focus|April 8, 2023
Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate LesionsVasilis Stavrinides, Ece Eksi, Ron Finn, et al.
Pageof 25